SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-01-501777
Filing Date
2001-06-26
Accepted
2001-06-26 00:00:00
Documents
3
Period of Report
2001-06-25
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. b39816tte8-k.txt 8-K 51002
2 UNDERWRITING AGREEMENT b39816ttex1-1.txt EX-1.1 99045
3 PRESS RELEASE, DATED JUNE 25, 2001 b39816ttex99-1.txt EX-99.1 2712
  Complete submission text file 0000950135-01-501777.txt   154423
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21481 | Film No.: 1667767
SIC: 2836 Biological Products, (No Diagnostic Substances)